DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Goldman Sachs - 2 Morgan Stanley - 2 Jefferies - 2 Nuvalent - 1 Bausch - 1 Donald Trump - 1 Ming - 1 Chi Kuo - 1
Top related locs:
California U.S China Gulf
Top related orgs:
Apple - 2 Financial Times - 1 FT - 1 Alcoa - 1 Intel – - 1 Bloomberg - 1 Intel - 1 Pentagon - 1

Search resuls for: "Nuvalent"


3 mentions found


☆ Stocks making the biggest moves midday: Nuvalent, Alcoa, Sprouts Farmers Market, Apple and more
  + stars: | 2024-09-16 | by ( Sean Conlon | ) www.cnbc.com   time to read: +3 min
Upstart Holdings – Shares of the personal finance firm fell 5% after the announcement of a new debt offering. Sprouts Farmers Market – Shares of the supermarket chain rose nearly 5% following an upgrade to outperform from in line at Evercore ISI. The investment firm wrote that Sprouts, which specializes in organic products, could be a beneficiary of a trend towards healthier eating. Apple – Shares slumped 3% following reports of sluggish demand for some of the company's latest iPhone models. Yelp – Shares dropped 4% after Bank of America initiated coverage of Yelp with an underperform rating.
Persons: Nuvalent, Bausch, Goldman Sachs, Morgan Stanley, Donald Trump, Ming, Chi Kuo, —, Alex Harring, Samantha Subin, Yun Li, Lisa Kailai Han, Pia Singh, Jesse Pound Organizations: Financial Times, FT, Alcoa, Intel –, Bloomberg, Intel, Pentagon, Micron Technology, Evercore ISI, Trump Media & Technology, Apple –, TF Securities, Apple, JPMorgan, Bank of America Locations: California
☆ This biotech stock specializing in targeted cancer treatments can surge 50%, Jefferies says
  + stars: | 2024-04-17 | by ( Pia Singh | ) www.cnbc.com   time to read: +2 min
Nuvalent could be a winning biotech in the world of cancer treatments, according to Jefferies. Analyst Roger Song initiated the clinical-stage biopharmaceutical company with a buy rating and $97 price target, which implies 49.8% potential upside for shares over the next 12 months. "NUVL leverages strong expertise in structure-based chemistry and deep understanding of unmet [patient] needs to develop potentially 'best-in-class' small molecule targeted cancer therapy," Song wrote in a Wednesday note. "We think both candidates poise well in later line and have strong potential to move into frontline treatments." The company posted a fourth-quarter loss that was slightly wider than expected, at 62 cents per share.
Persons: Roger Song, Jefferies Organizations: Jefferies, U.S . Food, Drug Administration, FactSet Locations: U.S
☆ Here are Wednesday's biggest analyst calls: Nvidia, Broadcom, Apple, Tesla, Netflix, Amazon, Microsoft & more
  + stars: | 2024-04-17 | by ( Michael Bloom | ) www.cnbc.com   time to read: +7 min
Here are Wednesday's biggest calls on Wall Street: Barclays reiterates Tesla as equal weight Barclays lowered its price target on Tesla to $180 per share from $225 and said it sees a negative catalyst heading into earnings. Wells Fargo reiterates Microsoft as overweight Wells raised its price target on the stock to $480 per share from $460. Barclays reiterates Broadcom as overweight Barclays raised its price target on Broadcom to $1,500 per share from $1,405. Wells Fargo reiterates Goldman Sachs as overweight Wells said it gives a "gold star" to Goldman coming out of earnings. Truist reiterates Amazon as buy Truist raised its price target on the stock to $216 per share from $195.
Persons: Tesla, Mizuho, RCL, Hancock Whitney, Raymond James, it's, Vernova, Wells, AAPL, TD Cowen, Jefferies, Morgan Stanley, NVDA, Goldman Sachs, Goldman, Maxim, Truist Organizations: Street, Barclays, Royal Caribbean, Citi, GE, HSBC, Biotech, Apple, Microsoft, Broadcom, Education, Strategic Education, Guggenheim, Automotive, Netflix Locations: China, Gulf
0 next >>
Total: 3